Pfizer spends $11.4bn on Array to bolster its oncology portfolio 17-Jun-2019 By Ben Hargreaves Pfizer will acquire Array to add Braftovi and Mektovi to its existing portfolio of oncology treatments to create ‘industry-leading franchise’.